- DESCRIPTION
- TABLE OF CONTENTS
- METHODOLOGY
- DOWNLOAD PDF
Ostomy Dressing Market by Product [Bags/Pouches (Colostomy, Urostomy, Ileostomy), Skin Barrier Sheets, Skin Barrier Rings, Film Dressings], Application (Cancer, Crohn's Disease), End User (Hospitals, Home Care, ASCs), and Region - Global Forecast to 2031
USD 4.73 BN
MARKET SIZE, 2031
OSTOMY DRESSINGS MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global ostomy dressings market is projected to grow from USD 3.80 billion in 2026 to USD 4.73 billion by 2031, at a CAGR of 4.4% during the forecast period. The market was valued at USD 3.67 billion in 2025. This growth is driven by the increasing incidence of colorectal cancer and inflammatory bowel diseases, along with an aging population that requires long-term ostomy care. Additionally, rising awareness of peristomal skin complications and a shift toward home-based care are further boosting the demand for advanced, user-friendly ostomy dressing products.
KEY TAKEAWAYS
-
BY REGION
By region, Europe accounted for the largest share of 45–55% of the ostomy dressings market in 2025.
-
BY PRODUCT
By product, the ostomy bags/pouches segment accounted for the largest share of 65–75% of the ostomy dressings market in 2025.
-
BY APPLICATION
By application, the cancer segment accounted for the largest share of 45–50% of the ostomy dressings market.
-
BY END USER
By end user, the home care settings segment held the largest share of 45–55% in the ostomy dressings market in 2025.
-
COMPETITIVE LANDSCAPE - KEY PLAYERS
Coloplast A/S, ConvaTec Group Plc, and Hollister Incorporated were recognized as star players due to their established strong product portfolios.
-
COMPETITIVE LANDSCAPE - STARTUPS
Fortis Medical Products and Avitr Farmica Pvt. Ltd. have established themselves among startups and SMEs due to their strong product portfolio and business strategies.
The ostomy dressings market is growing due to the increasing global incidence of colorectal cancer, inflammatory bowel diseases, and trauma cases that necessitate ostomy procedures. Improved survival rates and an aging population are contributing to a larger long-term patient base, which drives steady demand for advanced skin protection and management solutions. Additionally, the trend toward home-based care, heightened awareness of peristomal skin complications, and continuous innovations in products focused on comfort, adhesion, and infection prevention are all factors that are accelerating market growth.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The market for ostomy dressings is evolving in response to changing patient expectations and the adoption of new technologies. The primary end users, mainly patients, are seeking greater comfort and safety through dressing products that incorporate advanced adhesives and innovative designs. The shift in care delivery from an institution-centered model to home-based care has created a demand for easy-to-use dressings and effective patient education. Additionally, the integration of digital technologies, such as telemedicine and telehealth platforms, is beginning to influence post-surgical care and patient adherence. Increased awareness of peristomal complications has also led to a rise in the use of preventive accessories like barrier rings and films. Furthermore, procurement costs and reimbursement issues have become significant factors in the decision-making process, especially in emerging markets.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
-
Post-surgical complications and quality-of-life concerns
OPPORTUNITIES
Impact
Level
-
Rising reimbursement support and awareness initiatives
-
Limited awareness and education among patients and caregivers
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The increasing prevalence of colorectal and bladder cancer is a significant factor driving the growth of the ostomy dressings market. These diseases often require surgeries that result in the formation of a stoma, either temporarily or permanently. The global burden of cancer is substantial, with approximately 1.46 million cases reported in India in 2022, around 4.82 million cases in China in the same year, and an estimated 979,300 cases in Japan by 2024. Additionally, Europe saw over 4.47 million cancer cases in 2022, with an expected mortality rate of about 1.23 million in the European Union by 2026. This high number of cancer patients contributes to a significant demand for ostomy devices.
The occurrence of post-surgery complications and related quality-of-life concerns significantly restricts the market, impacting product adoption and compliance. Patients often experience complications such as skin irritation around the surgical site, leakage, infections, and stoma issues, which can undermine their confidence in using ostomy dressing products. Additionally, psychological barriers like stigma and mobility challenges further limit patients' willingness to try and adhere to new products. In some cases, these issues may lead them to completely avoid using these products or seek alternative solutions when possible. Consequently, despite the clinical necessity of these products, such factors hinder market penetration and highlight the need for more patient-centric, reliable, and comfortable options.
Increasing reimbursements and raising awareness present significant opportunities for the growth of the ostomy dressings market. The greater availability and adoption of ostomy dressing products contribute to this trend. In developed countries and select developing nations, increased reimbursements help lower costs for patients, enabling them to access the best ostomy dressing products. Additionally, growing awareness of issues such as peristomal skin problems, hygiene, and post-surgery management is driving demand for high-quality, preventive products. Furthermore, higher rates of diagnosis and counseling are supporting patients in successfully transitioning to long-term management of their conditions. Together, these factors are enhancing market penetration, boosting recurring demand, and creating opportunities for value-added product offerings.
Low levels of awareness and poor patient education pose as a significant challenge for the growth of the ostomy dressing market. This is due to their role in the adoption and use of ostomy dressing products. Due to limited awareness about the care of stomas, selection of products, and managing complications related to this practice, many patients, especially in emerging economies are found to improperly use products, which results in an increased frequency of leakage and peristomal skin problems. Social stigma is another factor that works against the popularity and adoption of these products. Consequently, despite clinical need, suboptimal education and training act as a barrier to consistent usage, patient adherence, and overall market expansion.
OSTOMY DRESSINGS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Offers a comprehensive range of ostomy care products, including both 1-piece and 2-piece pouching systems, skin barrier rings, and accessories designed to prevent leakage and protect the skin | There is a strong emphasis on patient-centric design and usability for home care | Enhances patient comfort and discretion, reduces leakage risk, and improves peristomal skin health | Supports long-term adherence and quality of life | Enables efficient self-management in home care settings |
|
|
Offers advanced ostomy systems, including moldable skin barriers, pouches, and accessories designed for customized fit and clinical reliability | Focuses on chronic care and post-surgical management | Improves seal integrity and reduces skin complications | Enhances wear time and reliability | Supports better clinical outcomes and reduces frequency of product changes |
|
|
Delivers integrated ostomy care portfolios, including pouching systems, skin protection products, and accessories, emphasizing ease of use and comfort | Strong patient education and support programs | Improves patient independence and confidence | Reduces complications through better usability | Enhances patient compliance and overall experience |
|
|
Provides ostomy management products, including bags, skin barriers, and accessories integrated with a broader wound and continence care portfolio | Focuses on clinical efficiency and safety | Ensures effective waste management and skin protection | Supports infection control and clinical safety | Improves workflow efficiency in hospital and post-acute care settings |
|
|
Specializes in personalized ostomy products, including pouches, seals, and skin-friendly adhesives with an emphasis on comfort and customization | Strong focus on patient-centric innovation | Enhances comfort and reduces skin irritation | Provides tailored solutions for diverse patient needs | Improves quality of life and long-term product satisfaction |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The ecosystem for the ostomy dressings market is a coordinated network of stakeholders involved in product innovation, regulation, production, marketing, and end-user engagement. Key players include global manufacturing companies such as Coloplast, ConvaTec Group plc, and Hollister Incorporated, which are responsible for product innovation, development, and large-scale distribution. These companies operate under a regulatory framework established by authorities like the US Food and Drug Administration, ensuring safety, efficacy, and compliance. Raw material manufacturers represent the upstream part of this ecosystem, while distributors and medical professionals are part of the downstream segment. Additionally, patient associations play a crucial role in raising awareness and educating patients in developing markets, ultimately increasing demand for these products. The market is characterized by a high level of interdependence, with value created from both the products and the associated services provided by participants in the ecosystem.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The ostomy bags/pouches segment was the dominant force in the ostomy dressings market in 2025, primarily due to its essential role in ostomy care. These products are crucial for waste collection and are necessary for all ostomy patients, resulting in consistent and ongoing demand. Unlike other accessories, pouches need to be replaced frequently, which drives higher consumption volumes. Additionally, continuous innovations in odor control, leakage prevention, comfort, and discreet design have improved patient preference and compliance. Strong clinical adoption, favorable reimbursement support, and a growing trend toward home-based care further reinforce this segment’s leading market share.
The cancer segment, which includes colon and bladder cancers, holds the largest share of the ostomy dressings market. This is primarily due to the high global incidence of colorectal and bladder cancers, which often require surgical procedures like colostomy and urostomy. These surgeries typically lead to the formation of temporary or permanent stomas, driving a sustained demand for ostomy bags and related dressings. Furthermore, improved survival rates among cancer patients extend the duration of product usage, resulting in increased recurring consumption. High surgical volumes, established clinical treatment pathways, and ongoing post-operative care requirements further solidify this segment's dominant position in the market.
Home care settings hold the largest share of the ostomy dressings market, primarily due to the extended use of ostomy bags, which often occurs outside of hospitals. Patients are typically discharged from hospitals shortly after surgery and begin using ostomy dressing products consistently at home. This trend is further supported by shorter hospital stays and lower healthcare costs. Additionally, enhanced patient education, caregiver support, and the availability of user-friendly products facilitate effective self-management.
REGION
Europe held largest share of ostomy dressings market in 2025
The ostomy dressings market in Europe holds a significant share due to the ongoing clinical burden, which results in a large patient population. In 2022, the region recorded over 4.47 million new cancer cases (BMC Cancer) and is projected to have approximately 1.23 million cancer-related deaths by 2026 (ESMO). Colorectal and bladder cancers are major contributors to the number of ostomy procedures performed. In the UK alone, there are about 165,000 to 205,000 individuals living with a stoma, indicating a strong need for long-term ostomy care. These factors are further supported by a well-established healthcare infrastructure, favorable reimbursement frameworks, and high levels of awareness and adoption of innovative ostomy dressings and accessories.
OSTOMY DRESSINGS MARKET: COMPANY EVALUATION MATRIX
In the ostomy dressings market, ConvaTec Group Plc and Coloplast A/S are leading companies, both recognized as stars due to their strong global presence, brand recognition, and extensive range of medical products. Solventum (US) and B. Braun SE are emerging leaders in this market and are quickly gaining traction with their ostomy dressing products, which cater to various applications.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Coloplast A/S (Denmark)
- ConvaTec Group Plc (UK)
- Hollister (US)
- Salts Healthcare (UK)
- B. Braun SE (Germany)
- Solventum (US)
- Welland Medical Limited (UK)
- ALCARE Co., Ltd. (Japan)
- Eakin Healthcare Group (Ireland)
- Marlen Manufacturing & Development (US)
- Advin Health Care (India)
- Nu-Hope Laboratories, Inc. (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 3.67 Billion |
| Market Size in 2031 (Value) | USD 4.73 Billion |
| Growth Rate | CAGR of 4.4% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion), Volume (Thousand Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regional Scope | North America, Asia Pacific, Europe, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: OSTOMY DRESSINGS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Further breakdown of other applications in the market | Insights on other applications involved in the market |
| Company Information | Market share analysis, by region (North America and Europe) and competitive leadership mapping for established players in the US | Insights on market share analysis by region |
| Geographic Analysis |
|
Country-level demand mapping for new product launches and localization strategy planning |
RECENT DEVELOPMENTS
- October 2025 : ConvaTec announced an investment of over USD 1 billion in research and development to accelerate innovation, strengthen its global growth strategy, and enhance its strategic presence in the US and UK markets.
- March 2025 : ConvaTec partnered with WOCN to launch educational programs aimed at strengthening clinical capabilities, addressing skill gaps, and enhancing standards of ostomy care through global professional training initiatives.
- May 2024 : Coloplast A/S expanded its SenSura Mio portfolio with the launch of SenSura Mio in black and SenSura Mio Convex Soft with Flex coupling. These additions reflect the company’s focus on product innovation and personalization, enhancing choice and comfort for people living with a stoma.
- February 2024 : ConvaTec announced the initial launch of Esteem Body with Leak Defense in Italy, marking the first market introduction. The company plans to expand to the US in April, followed by a phased rollout across global emerging markets.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
4
MARKET OVERVIEW
38
4.2.1.1
RISE IN COLORECTAL AND BLADDER CANCER INCIDENCE ACCELERATES LONG-TERM DEMAND FOR OSTOMY DRESSING PRODUCTS
4.2.1.2
RISE IN IBD PREVALENCE DRIVING SUSTAINED DEMAND FOR OSTOMY DRESSINGS PRODUCTS
4.2.2.1
POST-SURGICAL COMPLICATIONS AND QUALITY-OF-LIFE CONCERNS ARE RESTRAINING OSTOMY DRESSING ADOPTION
4.2.3.1
INCREASE IN REIMBURSEMENT SUPPORT AND AWARENESS INITIATIVES DRIVE ADOPTION IN EMERGING MARKETS
4.2.4.1
LIMITED AWARENESS AND EDUCATION AMONG PATIENTS AND CAREGIVERS
4.3
UNMET NEEDS AND WHITE SPACES
4.3.1
UNMET NEEDS IN OSTOMY DRESSINGS MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
43
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
BARGAINING POWER OF SUPPLIERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN STOMA CARE INDUSTRY
5.2.4
TRENDS IN GLOBAL WOUND CARE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR VARIOUS PRODUCTS
5.6.2
AVERAGE SELLING PRICE TREND, BY REGION
5.7.1
IMPORT SCENARIO (HS CODE 300691)
5.7.2
EXPORT DATA (HS CODE 300691)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.11
IMPACT OF 2025 US TARIFFS - OSTOMY DRESSINGS MARKET
5.11.3
PRICE IMPACT ANALYSIS
5.11.4
IMPACT ON COUNTRIES/REGIONS
5.11.5
END-USE INDUSTRY IMPACT
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
60
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
ADVANCED SKIN BARRIER TECHNOLOGIES
6.1.2
LEAK PREVENTION & FLEXIBLE ADHESIVE SYSTEMS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
DERMATOLOGY AND SKIN CARE TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.3.1
SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2
MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION
6.3.3
LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4.1
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.5.1
SMART OSTOMY SYSTEMS AND DIGITAL SUPPORT
6.5.2
SUSTAINABLE AND ECO-FRIENDLY OSTOMY PRODUCTS
6.6
IMPACT OF AI/GEN AI ON OSTOMY DRESSINGS MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.7
BEST PRACTICES IN OSTOMY DRESSING PROCESSING
6.7.1
CASE STUDIES OF AI IMPLEMENTATION IN OSTOMY DRESSINGS MARKET
6.7.2
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.3
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN OSTOMY DRESSINGS MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
67
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
CARBON IMPACT AND ECO-APPLICATIONS OF OSTOMY DRESSINGS MARKET
7.2.1.1
CARBON IMPACT REDUCTION
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
7.5
REIMBURSEMENT ANALYSIS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
72
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2
KEY BUYING CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9
OSTOMY DRESSINGS MARKET, BY PRODUCT
76
9.2.1
COLOSTOMY BAGS/POUCHES
9.2.1.1
RISE IN COLORECTAL CANCER BURDEN TO DRIVE SUSTAINED DEMAND FOR COLOSTOMY BAGS
9.2.2
ILEOSTOMY BAGS/POUCHES
9.2.2.1
RISE IN PREVALENCE OF INFLAMMATORY BOWEL DISEASES TO FUEL GROWTH OF ILEOSTOMY BAGS
9.2.3
UROSTOMY BAGS/POUCHES
9.2.3.1
INCREASE IN BLADDER CANCER INCIDENCE TO SUPPORT SUSTAINED DEMAND FOR UROSTOMY BAGS
9.3.1
INCREASE IN FOCUS ON PERISTOMAL SKIN PROTECTION AND COMPLICATION PREVENTION TO FUEL GROWTH OF SKIN BARRIER SHEETS
9.4.1
RISE IN FOCUS ON LEAKAGE PREVENTION AND SKIN PROTECTION DRIVING GROWTH OF OSTOMY SKIN BARRIER RINGS
9.5.1
GROWTH IN EMPHASIS ON PREVENTIVE SKIN CARE AND ADHESION SUPPORT TO SUPPORT ADOPTION OF OSTOMY FILM DRESSINGS
10
OSTOMY DRESSINGS MARKET, BY APPLICATION
86
10.2
CANCER (COLON, BLADDER)
10.2.1
CONTINUOUS USAGE OF RELIABLE, HIGH-PERFORMANCE PRODUCTS ACROSS EXTENDED CANCER SURVIVAL PERIODS TO DRIVE CONSUMPTION VOLUMES
10.3.1
LIFELONG MANAGEMENT OF CROHN’S DISEASE WITH POTENTIAL FOR MULTIPLE SURGERIES INCREASES DEPENDENCY ON OSTOMY CARE SOLUTIONS
10.4.1
DEPENDENCY ON OSTOMY DRESSINGS FOR POST-SURGICAL MANAGEMENT DURING RECOVERY OR LONG-TERM CARE TO DRIVE CONSISTENT DEMAND
10.5.1
CHRONIC NATURE OF UC, COMBINED WITH INCREASING INCIDENCE AND LONG-TERM DISEASE MANAGEMENT, TO DRIVE SUSTAINED DEMAND
11
OSTOMY DRESSINGS MARKET, BY END USER
93
11.2.1
HOME CARE SETTINGS SEGMENT HELD MAJOR SHARE IN MARKET
11.3.1
HIGH VOLUME OF OSTOMY SURGERIES IN HOSPITALS TO DRIVE SIGNIFICANT DEMAND
11.4
AMBULATORY SURGICAL CENTERS
11.4.1
GROWTH IN COST-EFFICIENT OUTPATIENT COLORECTAL PROCEDURES TO DRIVE SEGMENTAL GROWTH
12
OSTOMY DRESSINGS MARKET, BY REGION
99
12.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2.1
US: LARGEST COUNTRY-LEVEL NORTH AMERICAN MARKET
12.2.3.1
RISE IN CANCER BURDEN AND AGING POPULATION TO DRIVE DEMAND
12.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2.1
GERMANY: LARGEST SHARE IN EUROPEAN OSTOMY DRESSINGS MARKET
12.3.3.1
ESTABLISHED STOMA PATIENT BASE DRIVING DEMAND
12.3.4.1
HIGH OSTOMY PATIENT BASE AND CANCER INCIDENCE TO FUEL DEMAND
12.3.5.1
RISE IN CANCER INCIDENCE AND ESTABLISHED STOMA PATIENT BASE TO DRIVE OSTOMY DRESSING PRODUCTS DEMAND
12.3.6.1
INCREASE IN UROSTOMY PROCEDURES TO DRIVE OSTOMY CARE DEMAND IN SPAIN
12.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2.1
CHINA: LARGEST SHARE IN ASIA PACIFIC OSTOMY DRESSINGS MARKET
12.4.3.1
RISING DISEASE BURDEN, WITH ADVANCED HEALTHCARE INFRASTRUCTURE, STRONG REIMBURSEMENT SYSTEMS, AND HIGH ADOPTION OF INNOVATIVE MEDICAL PRODUCTS, IN JAPAN
12.4.4.1
RISE IN CANCER INCIDENCE AND EXPANDING ACCESS TO SURGICAL CARE TO SUPPORT DEMAND
12.4.5.1
ESTABLISHED PATIENT BASE AND STRONG HEALTHCARE INFRASTRUCTURE, REIMBURSEMENT SUPPORT THROUGH NATIONAL PROGRAMS TO AID MARKET GROWTH
12.4.6.1
INCREASE IN CANCER INCIDENCE TO AID GROWTH OF OSTOMY DRESSINGS MARKET IN SOUTH KOREA
12.4.7
REST OF ASIA PACIFIC
12.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2.1
BRAZIL: LARGEST SHARE IN LATIN AMERICAN MARKET
12.5.3.1
POPULATION PRONE TO CANCER AND GASTROINTESTINAL DISORDERS AND AGING TO CONTRIBUTE TO MARKET GROWTH
12.5.4
REST OF LATIN AMERICA
12.6
MIDDLE EAST & AFRICA
12.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2.1
RISE IN CANCER INCIDENCE AND STRONG HEALTHCARE INFRASTRUCTURE TO AID MARKET GROWTH
12.6.3
REST OF MIDDLE EAST & AFRICA
13
COMPETITIVE LANDSCAPE
147
13.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OSTOMY DRESSINGS MARKET
13.3
REVENUE ANALYSIS, 2021–2025
13.4
MARKET SHARE ANALYSIS, 2025
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGIONAL FOOTPRINT
13.5.5.3
PRODUCT FOOTPRINT
13.5.5.4
APPLICATION FOOTPRINT
13.5.5.5
END-USER FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.7
COMPANY VALUATION & FINANCIAL METRICS
13.8
BRAND/PRODUCT COMPARISON
13.9
COMPETITIVE SCENARIO
13.9.1
PRODUCT LAUNCHES & APPROVALS
14
COMPANY PROFILES
165
14.1.1.1
BUSINESS OVERVIEW
14.1.1.2
PRODUCTS OFFERED
14.1.1.3
RECENT DEVELOPMENTS
14.1.1.3.1
PRODUCT LAUNCHES & APPROVALS
14.1.1.4.2
STRATEGIC CHOICES
14.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
14.1.2
CONVATEC GROUP PLC
14.1.4
HOLLISTER INCORPORATED
14.1.8
WELLAND MEDICAL LIMITED
14.1.11
MARLEN MANUFACTURING & DEVELOPMENT COMPANY
14.2.3
NU-HOPE LABORATORIES, INC.
14.2.5
TORBOT, A DIVISION OF SAFETEC
14.2.6
FOR LIFE PRODUKTIONS
14.2.7
FORTIS MEDICAL PRODUCTS
14.2.8
ANGIPLAST PRIVATE LIMITED
14.2.10
TRIO HEALTHCARE LTD
14.2.11
AVITR FARMICA PVT LTD.
14.2.12
CRIMSON HEALTHCARE PVT. LTD
14.2.13
WUJIANG EVERGREEN EX/IM CO., LTD.
15
RESEARCH METHODOLOGY
217
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
15.1.2.2
KEY INDUSTRY INSIGHTS
15.2
MARKET SIZE ESTIMATION
15.4
MARKET RANKING ANALYSIS
15.6
RESEARCH LIMITATIONS
15.6.1
METHODOLOGY-RELATED LIMITATIONS
15.6.2
SCOPE-RELATED LIMITATIONS
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
TABLE 1
OSTOMY DRESSINGS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES
TABLE 3
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
TABLE 4
OSTOMY DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5
GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030
TABLE 6
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023–2025 (USD)
TABLE 7
AVERAGE PRICING TREND OF OSTOMY DRESSING, BY REGION, 2023–2025 (USD)
TABLE 8
IMPORT DATA FOR OSTOMY DRESSING UNDER HS CODE 300691, BY COUNTRY, 2019–2024 (USD THOUSAND)
TABLE 9
EXPORT DATA FOR OSTOMY DRESSING UNDER HS CODE 300691, BY COUNTRY, 2019–2024 (USD THOUSAND)
TABLE 10
OSTOMY DRESSINGS MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 11
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 12
KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR OSTOMY DRESSING PRODUCTS
TABLE 13
SMART OSTOMY SYSTEMS AND DIGITAL SUPPORT
TABLE 14
SUSTAINABLE AND ECO-FRIENDLY OSTOMY PRODUCTS
TABLE 15
TOP USE CASES AND MARKET POTENTIAL
TABLE 16
OSTOMY DRESSINGS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
TABLE 17
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 18
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
GLOBAL STANDARDS IN OSTOMY DRESSINGS MARKET
TABLE 24
CERTIFICATIONS, LABELING, ECO-STANDARDS IN OSTOMY DRESSINGS MARKET
TABLE 25
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR OSTOMY DRESSING PRODUCTS
TABLE 26
KEY BUYING CRITERIA FOR TOP THREE OSTOMY DRESSING PRODUCTS
TABLE 27
OSTOMY DRESSINGS MARKET: UNMET NEEDS/END-USER EXPECTATIONS
TABLE 28
OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 29
OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 30
COLOSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31
ILEOSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32
UROSTOMY BAGS/POUCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 33
OSTOMY SKIN BARRIER SHEETS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34
OSTOMY SKIN BARRIER RINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35
OSTOMY FILM DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36
OTHER OSTOMY DRESSING PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37
OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 38
OSTOMY DRESSINGS MARKET IN CANCER TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39
OSTOMY DRESSINGS MARKET IN CROHN’S DISEASE TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40
OSTOMY DRESSINGS MARKET IN TRAUMATIC INJURY TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41
OSTOMY DRESSINGS MARKET IN ULCERATIVE COLITIS TREATMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
OSTOMY DRESSINGS MARKET IN OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43
OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 44
OSTOMY DRESSINGS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45
OSTOMY DRESSINGS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46
OSTOMY DRESSINGS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47
OSTOMY DRESSINGS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48
OSTOMY DRESSINGS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 49
NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50
NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 51
NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 52
NORTH AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 53
NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 54
NORTH AMERICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 55
US: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 56
US: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 57
US: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 58
US: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 59
CANADA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 60
CANADA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 61
CANADA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 62
CANADA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 63
EUROPE: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64
EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 65
EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 66
EUROPE: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 67
EUROPE: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 68
EUROPE: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 69
GERMANY: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 70
GERMANY: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 71
GERMANY: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 72
GERMANY: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 73
UK: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 74
UK: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 75
UK: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 76
UK: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 77
FRANCE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 78
FRANCE: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 79
FRANCE: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 80
FRANCE: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 81
ITALY: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 82
ITALY: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83
ITALY: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 84
ITALY: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 85
SPAIN: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 86
SPAIN: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 87
SPAIN: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 88
SPAIN: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 89
REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 90
REST OF EUROPE: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 91
REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 92
REST OF EUROPE: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 93
ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 94
ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 95
ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 96
ASIA PACIFIC: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 97
ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 98
ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 99
CHINA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 100
CHINA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 101
CHINA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 102
CHINA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 103
JAPAN: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 104
JAPAN: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105
JAPAN: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 106
JAPAN: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 107
INDIA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 108
INDIA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109
INDIA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 110
INDIA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 111
AUSTRALIA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 112
AUSTRALIA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113
AUSTRALIA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 114
AUSTRALIA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 115
SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 116
SOUTH KOREA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117
SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 118
SOUTH KOREA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 119
REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 120
REST OF ASIA PACIFIC: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 121
REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 122
REST OF ASIA PACIFIC: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 123
LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 124
LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 125
LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 126
LATIN AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127
LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 128
LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 129
BRAZIL: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 130
BRAZIL: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131
BRAZIL: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 132
BRAZIL: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 133
MEXICO: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 134
MEXICO: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135
MEXICO: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 136
MEXICO: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 137
REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 138
REST OF LATIN AMERICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139
REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 140
REST OF LATIN AMERICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 141
MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 142
MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 143
MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 144
MIDDLE EAST & AFRICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145
MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 146
MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 147
GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 148
GCC COUNTRIES: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149
GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 150
GCC COUNTRIES: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 151
REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 152
REST OF MIDDLE EAST & AFRICA: OSTOMY BAGS/POUCHES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153
REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 154
REST OF MIDDLE EAST & AFRICA: OSTOMY DRESSINGS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 155
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN OSTOMY DRESSINGS MARKET
TABLE 156
OSTOMY DRESSINGS MARKET: DEGREE OF COMPETITION
TABLE 157
OSTOMY DRESSINGS MARKET: REGIONAL FOOTPRINT, 2025
TABLE 158
OSTOMY DRESSINGS MARKET: PRODUCT FOOTPRINT, 2025
TABLE 159
OSTOMY DRESSINGS MARKET: APPLICATION FOOTPRINT, 2025
TABLE 160
OSTOMY DRESSINGS MARKET: END-USER FOOTPRINT, 2025
TABLE 161
OSTOMY DRESSINGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
TABLE 162
OSTOMY DRESSINGS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025
TABLE 163
OSTOMY DRESSINGS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MARCH 2026
TABLE 164
OSTOMY DRESSINGS MARKET: DEALS, JANUARY 2022–MARCH 2026
TABLE 165
OSTOMY DRESSINGS MARKET: EXPANSIONS, JANUARY 2022–MARCH 2026
TABLE 166
COLOPLAST A/S: COMPANY OVERVIEW
TABLE 167
COLOPLAST A/S: PRODUCTS OFFERED
TABLE 168
COLOPLAST A/S: PRODUCT LAUNCHES & APPROVALS
TABLE 169
COLOPLAST A/S: DEALS
TABLE 170
COLOPLAST A/S: EXPANSIONS
TABLE 171
CONVATEC GROUP PLC: COMPANY OVERVIEW
TABLE 172
CONVATEC GROUP PLC: PRODUCTS OFFERED
TABLE 173
CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS
TABLE 174
CONVATEC GROUP PLC: DEALS
TABLE 175
CONVATEC GROUP PLC: EXPANSIONS
TABLE 176
B BRAUN SE: COMPANY OVERVIEW
TABLE 177
B BRAUN SE: PRODUCTS OFFERED
TABLE 178
HOLLISTER INCORPORATED: COMPANY OVERVIEW
TABLE 179
HOLLISTER INCORPORATED: PRODUCTS OFFERED
TABLE 180
HOLLISTER INCORPORATED: PRODUCT LAUNCHES & APPROVALS
TABLE 181
HOLLISTER INCORPORATED: EXPANSIONS
TABLE 182
HOLLISTER INCORPORATED: OTHER DEVELOPMENTS
TABLE 183
SOLVENTUM: COMPANY OVERVIEW
TABLE 184
SOLVENTUM: PRODUCTS OFFERED
TABLE 185
SOLVENTUM: OTHER DEVELOPMENTS
TABLE 186
ADVIN HEALTH CARE: COMPANY OVERVIEW
TABLE 187
ADVIN HEALTH CARE: PRODUCTS OFFERED
TABLE 188
ADVIN HEALTH CARE: EXPANSIONS
TABLE 189
SALTS HEALTHCARE: COMPANY OVERVIEW
TABLE 190
SALTS HEALTHCARE: PRODUCTS OFFERED
TABLE 191
WELLAND MEDICAL LIMITED: COMPANY OVERVIEW
TABLE 192
WELLAND MEDICAL LIMITED.: PRODUCTS OFFERED
TABLE 193
WELLAND MEDICAL LIMITED: PRODUCT LAUNCHES & APPROVALS
TABLE 194
WELLAND MEDICAL LIMITED: DEALS
TABLE 195
ALCARE CO., LTD.: COMPANY OVERVIEW
TABLE 196
ALCARE CO., LTD.: PRODUCTS OFFERED
TABLE 197
EAKIN: COMPANY OVERVIEW
TABLE 198
EAKIN: PRODUCTS OFFERED
TABLE 199
EAKIN: EXPANSIONS
TABLE 200
MARLEN MANUFACTURING & DEVELOPMENT COMPANY: COMPANY OVERVIEW
TABLE 201
MARLEN MANUFACTURING & DEVELOPMENT COMPANY: PRODUCTS OFFERED
TABLE 202
CYMED: COMPANY OVERVIEW
TABLE 203
ADVACARE PHARMA: COMPANY OVERVIEW
TABLE 204
NU-HOPE LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 205
SAFE N SIMPLE LLC: COMPANY OVERVIEW
TABLE 206
TORBOT, A DIVISION OF SAFETEC: COMPANY OVERVIEW
TABLE 207
FOR LIFE PRODUKTIONS: COMPANY OVERVIEW
TABLE 208
FORTIS MEDICAL PRODUCTS: COMPANY OVERVIEW
TABLE 209
ANGIPLAST PRIVATE LIMITED: COMPANY OVERVIEW
TABLE 210
PROWESS CARE: COMPANY OVERVIEW
TABLE 211
TRIO HEALTHCARE LTD: COMPANY OVERVIEW
TABLE 212
AVITR FARMICA PVT LTD.: COMPANY OVERVIEW
TABLE 213
CRIMSON HEALTHCARE PVT. LTD: COMPANY OVERVIEW
TABLE 214
WUJIANG EVERGREEN EX/IM CO., LTD.: COMPANY OVERVIEW
TABLE 215
OSTOFORM: COMPANY OVERVIEW
TABLE 216
OSTOMY DRESSINGS MARKET: STUDY ASSUMPTIONS
TABLE 217
OSTOMY DRESSINGS MARKET: RISK ASSESSMENT ANALYSIS
FIGURE 1
OSTOMY DRESSINGS MARKET: SEGMENTS CONSIDERED
FIGURE 2
YEARS CONSIDERED
FIGURE 3
KEY INSIGHTS AND MARKET HIGHLIGHTS
FIGURE 4
OSTOMY DRESSINGS MARKET, 2026–2031 (USD MILLION)
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN OSTOMY DRESSINGS MARKET
FIGURE 6
DISRUPTIVE TRENDS IMPACTING GROWTH OF OSTOMY DRESSINGS MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN OSTOMY DRESSINGS MARKET, 2025
FIGURE 8
EUROPE TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
FIGURE 9
RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
FIGURE 10
HOME CARE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN OSTOMY DRESSINGS MARKET IN 2025
FIGURE 11
CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 12
EUROPE ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 13
EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 14
OSTOMY DRESSINGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15
OSTOMY DRESSINGS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 16
OSTOMY DRESSINGS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 17
OSTOMY DRESSINGS MARKET: VALUE CHAIN ANALYSIS
FIGURE 18
OSTOMY DRESSINGS MARKET: ECOSYSTEM ANALYSIS
FIGURE 19
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 20
OSTOMY DRESSINGS MARKET: INVESTMENT & FUNDING SCENARIO
FIGURE 21
NUMBER OF PATENTS PUBLISHED, JANUARY 2015–APRIL 2026
FIGURE 22
TOP APPLICANT COUNTRIES/REGIONS FOR OSTOMY PRODUCTS, JANUARY 2015− OCTOBER 2025 (NUMBER OF PATENTS)
FIGURE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR OSTOMY DRESSING PRODUCTS
FIGURE 24
KEY BUYING CRITERIA FOR TOP THREE OSTOMY DRESSING PRODUCTS
FIGURE 25
OSTOMY DRESSINGS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 26
EUROPE: OSTOMY DRESSINGS MARKET SNAPSHOT
FIGURE 27
ASIA PACIFIC: OSTOMY DRESSINGS MARKET SNAPSHOT
FIGURE 28
REVENUE ANALYSIS OF KEY PLAYERS IN OSTOMY DRESSINGS MARKET, 2021–2025 (USD MILLION)
FIGURE 29
MARKET SHARE ANALYSIS OF KEY PLAYERS IN OSTOMY DRESSINGS MARKET (2025)
FIGURE 30
OSTOMY DRESSINGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31
OSTOMY DRESSINGS MARKET: COMPANY FOOTPRINT, 2025
FIGURE 32
OSTOMY DRESSINGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33
EV/EBITDA OF KEY VENDORS, 2026
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026
FIGURE 35
OSTOMY DRESSINGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 36
COLOPLAST A/S: COMPANY SNAPSHOT, 2025
FIGURE 37
CONVATEC GROUP PLC: COMPANY SNAPSHOT, 2025
FIGURE 38
B BRAUN SE: COMPANY SNAPSHOT, 2024
FIGURE 39
SOLVENTUM: COMPANY SNAPSHOT, 2025
FIGURE 40
RESEARCH DESIGN
FIGURE 41
PRIMARY SOURCES
FIGURE 42
PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 43
MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 44
TOP-DOWN APPROACH
FIGURE 45
BOTTOM-UP APPROACH
FIGURE 46
IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2026–2031
FIGURE 47
OSTOMY DRESSINGS MARKET: CAGR PROJECTIONS
FIGURE 48
DATA TRIANGULATION METHODOLOGY
Methodology
The research study aimed to estimate the current market size of the ostomy dressings market through several key activities. Comprehensive secondary research was conducted to gather information on the ostomy dressing industry. The next step involved validating these findings, assumptions, and size estimates with industry experts across the value chain through primary research. To estimate the total market size, both top-down and bottom-up approaches were utilized. Following this, market segmentation and data triangulation procedures were employed to determine the sizes of different segments and subsegments within the ostomy dressings market.
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources, such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global ostomy dressing market study. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends, and key developments from market and technology perspectives, down to the bottom-most level. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts, such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the ostomy dressings market. The primary demand-side sources include ambulatory surgical centers, hospitals, clinics, long-term & nursing facilities, and other end users. Primary research was conducted to validate the market segmentation, identify key players and gather insights into key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. The tiers are as follows:
Tier 1 = > USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenue figures were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global ostomy dressings market. All major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global ostomy dressings market was split into various segments and sub-segments:
- List of major players operating in the products market at the regional and/or country level
- Product mapping of various ostomy dressing manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from ostomy dressing (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global ostomy dressings market
The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Ostomy Dressings Market : Top-Down and Bottom-Up Approach
Data Triangulation
After determining the overall size of the global ostomy dressings market using the methodology described above, the market was segmented into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Market Definition
The ostomy dressings market comprises products designed to manage stoma care following ostomy creation. This procedure diverts bodily waste through an opening in the abdomen. The market encompasses ostomy bags or pouches, skin barrier rings and sheets, film dressings, and various accessories intended to protect the skin, prevent leakage, and maintain hygiene. These products are commonly used by individuals with conditions such as colorectal and bladder cancer, Crohn’s disease, ulcerative colitis, and traumatic injuries.
Key Stakeholders
- Suppliers and distributors of ostomy dressing products & other related components
- Ostomy care product manufacturers
- Hospitals & specialty clinics
- Patients
- Ambulatory surgery centers
- Raw material suppliers
- Third-party ostomy care product suppliers
- Government bodies and regulatory bodies
- Business research and consulting service providers
- Venture capitalists
Report Objectives
- To define, describe, segment, and forecast the ostomy dressings market by product, application, end user, and region
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall ostomy dressings market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the ostomy dressings market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the ostomy dressings market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the ostomy dressings market
- To benchmark players within the ostomy dressings market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Available customizations:
Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe ostomy dressings market into Russia, Switzerland, Denmark, Austria, and others
- Further breakdown of the Rest of Asia Pacific ostomy dressings market into South Korea, Taiwan, and others
- Further breakdown of the Rest of Latin America ostomy dressings market into Argentina, Colombia, Chile, Ecuador, and others
- Further breakdown of the Southeast Asia ostomy dressings market into Malaysia, Singapore, Australia, New Zealand, and others
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Ostomy Dressing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Previous Next
